Induction treatment in severe active Crohn’ s disease The efficacy of a single dose treatment with infliximab was assessed in 108 patients with active Crohn’ s disease (Crohn’ s Disease Activity Index (CDAI) ≥ 220 ≤ 400) in a randomised, double- blinded, placebo-controlled, dose-response study.